• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of the Effect of Operator Experience on Outcome of Hepatic Artery Embolization of Hepatocellular Carcinoma in a Tertiary Cancer Center.评价在一家三级肿瘤中心行肝癌肝动脉栓塞术的术者经验对治疗效果的影响。
Acad Radiol. 2018 Jul;25(7):856-860. doi: 10.1016/j.acra.2017.12.011. Epub 2018 Feb 1.
2
Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.对于直径大于5厘米的不可切除肝细胞癌,经动脉栓塞联合立体定向体部放疗与立体定向体部放疗单药治疗的长期生存分析
BMC Cancer. 2016 Nov 3;16(1):834. doi: 10.1186/s12885-016-2894-9.
3
Interstitial Brachytherapy in Combination With Previous Transarterial Embolization in Patients With Unresectable Hepatocellular Carcinoma.不可切除肝细胞癌患者间质近距离放射治疗联合既往经动脉栓塞术
Anticancer Res. 2019 Mar;39(3):1329-1336. doi: 10.21873/anticanres.13245.
4
Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.经动脉单纯栓塞与化疗栓塞治疗肝细胞癌:重新审视金标准
J Surg Res. 2016 Feb;200(2):552-9. doi: 10.1016/j.jss.2015.09.034. Epub 2015 Oct 3.
5
Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.肌少症作为不可切除肝细胞癌患者行单纯经动脉栓塞治疗后生存的预测因子。
PLoS One. 2020 Jun 17;15(6):e0232371. doi: 10.1371/journal.pone.0232371. eCollection 2020.
6
Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.经动脉放射性栓塞与化疗栓塞治疗肝细胞癌(TRACE):一项随机对照试验的研究方案。
Trials. 2012 Aug 23;13:144. doi: 10.1186/1745-6215-13-144.
7
Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.经动脉栓塞治疗自发性破裂肝细胞癌的疗效及预后因素
Acta Radiol. 2011 Apr 1;52(3):331-5. doi: 10.1258/ar.2010.100369. Epub 2011 Mar 3.
8
Survival outcome of patients with spontaneously ruptured hepatocellular carcinoma treated surgically or by transarterial embolization.自发性破裂肝细胞癌患者手术治疗与经动脉栓塞治疗的生存结局。
World J Gastroenterol. 2013 Jul 28;19(28):4537-44. doi: 10.3748/wjg.v19.i28.4537.
9
Hepatic embolization through extrahepatic collateral pathways after hepatic arterial embolization for the hepatocellular carcinoma.肝细胞癌肝动脉栓塞术后经肝外 collateral 途径的肝栓塞
Tokai J Exp Clin Med. 1996 Dec;21(4-6):177-83.
10
Does Enhancement or Perfusion on Preprocedure CT Predict Outcomes After Embolization of Hepatocellular Carcinoma?术前 CT 增强或灌注能否预测肝癌栓塞治疗后的结局?
Acad Radiol. 2018 Dec;25(12):1588-1594. doi: 10.1016/j.acra.2018.02.027. Epub 2018 Mar 27.

引用本文的文献

1
TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization.TP53突变预示经动脉栓塞治疗的肝细胞癌患者生存期更差且局部进展更早。
Curr Oncol. 2025 Jan 18;32(1):51. doi: 10.3390/curroncol32010051.
2
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization.Y90 放射性栓塞治疗经动脉栓塞治疗后的肝细胞癌患者的结果。
Curr Oncol. 2024 May 8;31(5):2650-2661. doi: 10.3390/curroncol31050200.
3
To Systematically Evaluate and Analyze the Efficacy and Safety of Transcatheter Arterial Chemoembolization (TACE) in the Treatment of Primary Liver Cancer.系统评价经导管肝动脉化疗栓塞术(TACE)治疗原发性肝癌的疗效及安全性。
J Healthc Eng. 2022 Mar 21;2022:8223336. doi: 10.1155/2022/8223336. eCollection 2022.
4
The Impact of Magnesium-Aluminum-Layered Double Hydroxide-Based Polyvinyl Alcohol Coated on Magnetite on the Preparation of Core-Shell Nanoparticles as a Drug Delivery Agent.基于镁铝水滑石的聚乙烯醇包覆的四氧化三铁对核壳纳米粒子作为药物传递剂的制备的影响。
Int J Mol Sci. 2019 Aug 1;20(15):3764. doi: 10.3390/ijms20153764.

本文引用的文献

1
Esophageal surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it.意大利的食管手术。确定有权开展该手术的医院科室及三级转诊中心的标准。
Updates Surg. 2016 Jun;68(2):129-33. doi: 10.1007/s13304-016-0374-z. Epub 2016 May 30.
2
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.多柔比星洗脱微球与单纯微球栓塞治疗肝细胞癌的肝动脉栓塞随机试验
J Clin Oncol. 2016 Jun 10;34(17):2046-53. doi: 10.1200/JCO.2015.64.0821. Epub 2016 Feb 1.
3
Cone-Beam CT Angiography for Determination of Tumor-Feeding Vessels During Chemoembolization of Liver Tumors: Comparison of Conventional and Dedicated-Software Analysis.锥形束CT血管造影术在肝肿瘤化疗栓塞术中用于确定肿瘤供血血管:传统分析与专用软件分析的比较
J Vasc Interv Radiol. 2016 Jan;27(1):32-8. doi: 10.1016/j.jvir.2015.09.010. Epub 2015 Nov 6.
4
Usefulness of Cone-Beam Computed Tomography and Automatic Vessel Detection Software in Emergency Transarterial Embolization.锥形束计算机断层扫描和自动血管检测软件在急诊经动脉栓塞中的应用价值
Cardiovasc Intervent Radiol. 2016 Apr;39(4):530-7. doi: 10.1007/s00270-015-1213-1. Epub 2015 Oct 20.
5
Supervisor volume affects oncological outcomes of trainees performing open radical prostatectomy.带教手术量影响实施开放性根治性前列腺切除术学员的肿瘤学治疗结果。
ANZ J Surg. 2016 Apr;86(4):249-54. doi: 10.1111/ans.13112. Epub 2015 Apr 28.
6
Evaluation of the Effect of Cumulative Operator Experience on Hepatocellular Carcinoma Recurrence after Primary Treatment with Radiofrequency Ablation.评估累积操作人员经验对原发性射频消融治疗后肝细胞癌复发的影响。
Radiology. 2015 Jul;276(1):294-301. doi: 10.1148/radiol.15141864. Epub 2015 Mar 12.
7
Learning curve in cryoballoon ablation of atrial fibrillation: eight-year experience.冷冻球囊消融治疗心房颤动的学习曲线:八年经验
Circ J. 2014;78(7):1612-8. doi: 10.1253/circj.cj-13-1253. Epub 2014 May 19.
8
Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.在经导管动脉化疗栓塞期间,使用锥形束 CT 引导技术识别小肝癌和肿瘤供养分支。
J Vasc Interv Radiol. 2013 Apr;24(4):501-8. doi: 10.1016/j.jvir.2012.12.022. Epub 2013 Feb 26.
9
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma.一项随机的 II/III 期试验,比较了 3 周为一个周期的基于顺铂的序贯经动脉化疗栓塞与单纯栓塞治疗肝细胞癌的效果。
Br J Cancer. 2013 Apr 2;108(6):1252-9. doi: 10.1038/bjc.2013.85. Epub 2013 Feb 28.
10
Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: a pilot study.三维锥形束计算机断层扫描血管造影术在肝肿瘤化疗栓塞术中用于确定肿瘤供血血管的计算机分析:一项初步研究。
Cardiovasc Intervent Radiol. 2010 Dec;33(6):1235-42. doi: 10.1007/s00270-010-9846-6.

评价在一家三级肿瘤中心行肝癌肝动脉栓塞术的术者经验对治疗效果的影响。

Evaluation of the Effect of Operator Experience on Outcome of Hepatic Artery Embolization of Hepatocellular Carcinoma in a Tertiary Cancer Center.

机构信息

Division of Interventional Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065.

Division of Interventional Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065.

出版信息

Acad Radiol. 2018 Jul;25(7):856-860. doi: 10.1016/j.acra.2017.12.011. Epub 2018 Feb 1.

DOI:10.1016/j.acra.2017.12.011
PMID:29358064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075412/
Abstract

RATIONALE AND OBJECTIVES

There is lack of information on the learning curve and the effect of operator's experience on the quality outcomes of transarterial hepatic embolization (TAE). The aim of this study was to evaluate the effect of operator experience on outcomes of TAE of hepatocellular carcinoma.

MATERIALS AND METHODS

Demographic characteristics and outcomes including overall survival (OS), time to local tumor progression (TLP), and post-procedure complications in patients with hepatocellular carcinoma treated with TAE were collected. Operators' experience was measured in years based on the years after completion of fellowship and the date of first embolization, and was divided into five groups: G1, less than 5 years of operator's experience (YOE) at the time of first embolization; G2, 5-10 YOE; G3, 10-15 YOE; G4, 15-20 YOE; and G5, more than 20 YOE. The effects of operator's experience and outcomes were assessed using linear regression.

RESULTS

From January 2012 to January 2015, 93 patients (age range = 30-86 years) were treated. The number of patients treated by each group was as follows: G1 = 12; G2 = 8; G3 = 23; G4 = 5; and G5 = 45. All groups were similar in regard to degree of cirrhosis, Barcelona Clinic Liver Cancer staging, and Child-Pugh score (P > .05). Median TLP was 8.8 months. TLP was 7.0, 6.8, 19.2, 7.9, and 8.2 months in G1, G2, G3, G4, and G5, respectively (P = .56). OS for 1, 2, and 3 years was 75%, 56%, and 42% for G1; 87%, 54%, and 54% for G2; 91%, 71%, and 45% for G3, 100%, 50%, and 0 for G4; and 84%, 65%, and 40% for G5.

CONCLUSION

Among interventional radiology fellowship-trained operators in a tertiary cancer center, OS, TLP, and post-procedure complications of TAE were not affected by the years of post-fellowship experience.

摘要

背景与目的

关于经动脉肝栓塞术(TAE)的学习曲线和操作者经验对治疗效果的影响,目前信息有限。本研究旨在评估操作者经验对肝细胞癌 TAE 治疗效果的影响。

材料与方法

收集了在我院接受 TAE 治疗的肝细胞癌患者的人口统计学特征和结局数据,包括总生存(OS)、局部肿瘤进展时间(TLP)和术后并发症。根据完成住院医师培训后的年限和首次栓塞术的日期,将操作者经验以年为单位进行测量,并分为 5 组:G1,首次栓塞时操作者经验不足 5 年(YOE);G2,5-10 YOE;G3,10-15 YOE;G4,15-20 YOE;G5,超过 20 YOE。使用线性回归评估操作者经验与结局的关系。

结果

2012 年 1 月至 2015 年 1 月,共治疗 93 例患者(年龄 30-86 岁)。每组患者数量分别为:G1 12 例;G2 8 例;G3 23 例;G4 5 例;G5 45 例。所有组在肝硬化程度、巴塞罗那临床肝癌分期和 Child-Pugh 评分方面均相似(P>.05)。中位 TLP 为 8.8 个月。G1、G2、G3、G4 和 G5 的 TLP 分别为 7.0、6.8、19.2、7.9 和 8.2 个月(P=.56)。G1 的 1、2、3 年 OS 分别为 75%、56%和 42%;G2 为 87%、54%和 54%;G3 为 91%、71%和 45%;G4 为 100%、50%和 0%;G5 为 84%、65%和 40%。

结论

在一家三级癌症中心接受介入放射学住院医师培训的医生中,OS、TLP 和 TAE 术后并发症不受住院医师培训后年限的影响。